Explore the latest in cardiovascular disease risk factors, including diabetes, dyslipidemia, hypertension, tobacco and smoking, and more.
This cohort study examines associations between hearing impairment, cardiovascular disease risk, and cognitive function in the Hispanic/Latino population in 4 US cities.
This randomized trial examines the effects on cardiovascular outcomes of a carboxylic acid formulation of EPA and DHA (omega-3 CA) with documented favorable effects on lipid and inflammatory markers in patients with atherogenic dyslipidemia and high cardiovascular risk.
This cross-sectional study includes younger and middle-aged adult participants from the China Patient-Centered Evaluative Assessment of Cardiac Events Million Persons Project to assess the prevalence, awareness, and individual characteristics of isolated systolic hypertension (ISH) among this population.
This randomized clinical trial examines the impact of delivering SLCO1B1 pharmacogenetic results to physicians on low-density lipoprotein cholesterol levels and concordance with prescribing guidelines for statin safety and effectiveness.
This subcohort study of Chinese adults examines the observational and genetic associations of adiposity with proteomics and the observational associations of adiposity with cardiovascular disease.
This cohort study investigates the association of the national health guidance intervention for obesity and cardiovascular risks with population health outcomes among working-age men in Japan.
This prognostic study evaluates the concordance between blood pressures obtained in routine clinical practice and those obtained using the Systolic Blood Pressure Intervention Trial protocol and whether concordance varied by target trial blood pressure.
This randomized clinical trial assesses the effects of a 16-week low-fat vegan dietary intervention on body weight, insulin resistance, postprandial metabolism, and intramyocellular and hepatocellular lipid levels in overweight adults.
This JAMA Patient Page reviews the 2020 US Preventive Services Task Force’s recommendation to offer behavioral counseling to promote healthy diet and physical activity to prevent cardiovascular disease in adults with CVD risk factors (B recommendation).
This systematic review to support the 2020 US Preventive Services Task Force Recommendation Statement on behavioral counseling to promote healthy diet and physical activity for cardiovascular disease (CVD) prevention summarizes published evidence on the benefits and harms of behavioral counseling to promote healthy diet and physical activity for CVD prevention in adults with cardiovascular risk factors.
This 2020 US Preventive Services Task Force Recommendation Statement recommends offering or referring adults with CVD risk factors to behavioral counseling interventions to promote a healthy diet and physical activity (B recommendation).
This cohort study assesses 10-year use, adherence, cost, and outcome trends in statin therapy for atherosclerotic cardiovascular disease in US adults using nationwide research center database information.
This cohort study characterizes the relative association of conventional and novel biomarkers in Mediterranean diet–related type 2 diabetes risk reduction in a US population.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: